FISH OIL

FISH OIL was reported 91008 times

FISH OIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATIC ENZYME 58 0.3893
1 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 139 0.2478
2 C-REACTIVE PROTEIN 223 0.2406
3 DEEP VEIN THROMBOSIS POSTOPERATIVE 472 0.2356
4 HYPOCHOLESTEROLAEMIA 83 0.2351
5 LUPUS VULGARIS 212 0.1683
6 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 111 0.1662
7 SWOLLEN JOINT COUNT INCREASED 474 0.1485
8 FACET JOINT SYNDROME 481 0.1476
9 X-RAY ABNORMAL 259 0.1447
10 PERIPHERAL VENOUS DISEASE 543 0.1328
11 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 271 0.1307
12 DISLOCATION OF VERTEBRA 296 0.1297
13 RHEUMATIC FEVER 536 0.1201
14 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 833 0.1161
15 DUODENAL ULCER PERFORATION 845 0.1135
16 RHEUMATOID FACTOR POSITIVE 642 0.1110
17 MUSCLE INJURY 901 0.1086
18 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 591 0.0909
19 FOLLICULITIS 895 0.0853
20 HELICOBACTER INFECTION 841 0.0817
21 C-REACTIVE PROTEIN ABNORMAL 509 0.0793
22 PEMPHIGUS 926 0.0740
23 PORPHYRIA ACUTE 100 0.0697
24 LIP DRY 627 0.0690
25 RETINITIS 110 0.0636
26 HAND DEFORMITY 831 0.0633
27 JOINT RANGE OF MOTION DECREASED 798 0.0594
28 PERICARDITIS 984 0.0585
29 BREAST CANCER STAGE III 358 0.0552
30 BURSITIS 670 0.0552
31 AUTOIMMUNE DISORDER 504 0.0517
32 SYNOVITIS 926 0.0513
33 IRRITABLE BOWEL SYNDROME 1079 0.0503
34 GLOSSODYNIA 1022 0.0456
35 BLEPHAROSPASM 278 0.0441
36 WOUND INFECTION 483 0.0441
37 PUSTULAR PSORIASIS 148 0.0430
38 EYELID PAIN 82 0.0403
39 HYPERCHOLESTEROLAEMIA 376 0.0389
40 DRUG TOLERANCE DECREASED 109 0.0388
41 FIBROMYALGIA 935 0.0384
42 OBESITY 598 0.0375
43 NIGHT SWEATS 1188 0.0368
44 ULCER HAEMORRHAGE 246 0.0363
45 ESSENTIAL HYPERTENSION 66 0.0360
46 RASH VESICULAR 171 0.0353
47 WALKING AID USER 228 0.0345
48 WOUND 965 0.0345
49 IMPAIRED HEALING 1085 0.0330
50 LIVE BIRTH 276 0.0330
51 SCIATICA 522 0.0327
52 BLOOD CHOLESTEROL INCREASED 1506 0.0323
53 HYPERPARATHYROIDISM SECONDARY 80 0.0319
54 GRIP STRENGTH DECREASED 280 0.0318
55 LOWER LIMB FRACTURE 602 0.0313
56 LIVER INJURY 768 0.0313
57 MUSCLE SPASTICITY 379 0.0308
58 FLUSHING 3070 0.0302
59 MATERNAL EXPOSURE TIMING UNSPECIFIED 113 0.0301
60 TYPE 2 DIABETES MELLITUS 1006 0.0299
61 REBOUND ACID HYPERSECRETION 89 0.0294
62 EXOSTOSIS 265 0.0290
63 PRE-EXISTING CONDITION IMPROVED 180 0.0288
64 NAIL DISORDER 252 0.0288
65 PSORIATIC ARTHROPATHY 1166 0.0287
66 NEPHROGENIC ANAEMIA 131 0.0283
67 BONE EROSION 97 0.0274
68 HIGH DENSITY LIPOPROTEIN DECREASED 91 0.0273
69 SYSTEMIC LUPUS ERYTHEMATOSUS 958 0.0270
70 LOWER RESPIRATORY TRACT INFECTION 1222 0.0268
71 EAR PAIN 517 0.0266
72 OSTEOARTHRITIS 1070 0.0252
73 CONTRAINDICATED PRODUCT ADMINISTERED 760 0.0251
74 PULMONARY FIBROSIS 476 0.0248
75 INFUSION SITE REACTION 73 0.0244
76 BREAST CANCER STAGE II 203 0.0244
77 HIP ARTHROPLASTY 371 0.0242
78 MUSCULOSKELETAL PAIN 1255 0.0239
79 EYE INJURY 72 0.0237
80 GAIT INABILITY 780 0.0233
81 ARTHROPATHY 1253 0.0225
82 STOMATITIS 1361 0.0224
83 BLISTER 1259 0.0224
84 PRESCRIBED OVERDOSE 416 0.0215
85 SINUSITIS 2203 0.0215
86 HAEMORRHAGIC ANAEMIA 92 0.0209
87 TASTE DISORDER 424 0.0209
88 INFUSION SITE HAEMORRHAGE 68 0.0206
89 BLOOD TESTOSTERONE DECREASED 141 0.0206
90 KNEE ARTHROPLASTY 427 0.0203
91 FEELING HOT 1234 0.0201
92 PLANTAR FASCIITIS 67 0.0200
93 GENERAL SYMPTOM 149 0.0199
94 AORTIC STENOSIS 69 0.0198
95 SEASONAL ALLERGY 274 0.0193
96 MYOSITIS 173 0.0193
97 HEPATIC ENZYME INCREASED 1309 0.0192
98 DISCOMFORT 1157 0.0189
99 BACK DISORDER 306 0.0188
100 CONTUSION 1801 0.0187
101 OEDEMA 1012 0.0186
102 DRY MOUTH 1508 0.0186
103 ONYCHOMADESIS 78 0.0186
104 BODY TEMPERATURE INCREASED 376 0.0184
105 TENDON PAIN 138 0.0182
106 WHEEZING 1072 0.0181
107 BODY HEIGHT DECREASED 191 0.0178
108 JOINT SWELLING 2156 0.0178
109 GLUCOSE TOLERANCE IMPAIRED 105 0.0177
110 SPINAL FUSION SURGERY 72 0.0177
111 UPPER-AIRWAY COUGH SYNDROME 144 0.0175
112 ROAD TRAFFIC ACCIDENT 730 0.0174
113 PRESCRIBED UNDERDOSE 346 0.0173
114 SLEEP APNOEA SYNDROME 327 0.0171
115 MUSCULOSKELETAL STIFFNESS 1490 0.0170
116 INFUSION RELATED REACTION 1114 0.0168
117 PERIPHERAL SWELLING 2587 0.0168
118 MOBILITY DECREASED 1201 0.0167
119 TRIGGER FINGER 68 0.0166
120 SLEEP DISORDER 1170 0.0166
121 MULTIPLE ALLERGIES 129 0.0164
122 GASTROOESOPHAGEAL REFLUX DISEASE 1323 0.0164
123 BLOOD CALCIUM INCREASED 144 0.0164
124 SWELLING 1533 0.0164
125 LUNG DISORDER 802 0.0163
126 EYE PAIN 923 0.0163
127 MENISCUS INJURY 100 0.0162
128 VITAMIN D DECREASED 139 0.0162
129 PARANASAL SINUS HYPERSECRETION 62 0.0162
130 BLOOD CHOLESTEROL ABNORMAL 75 0.0162
131 RESPIRATORY DISORDER 485 0.0162
132 FOOT DEFORMITY 177 0.0160
133 THYROID FUNCTION TEST ABNORMAL 66 0.0159
134 SPINAL COLUMN STENOSIS 75 0.0159
135 PRODUCT ADMINISTRATION INTERRUPTED 124 0.0158
136 PROSTATOMEGALY 62 0.0158
137 LOW DENSITY LIPOPROTEIN INCREASED 122 0.0157
138 ONYCHOMYCOSIS 69 0.0157
139 INTERVERTEBRAL DISC DEGENERATION 145 0.0157
140 URINE ABNORMALITY 71 0.0156
141 HYPERLIPIDAEMIA 186 0.0155
142 BACK INJURY 168 0.0154
143 SKIN ABRASION 73 0.0154
144 INFLAMMATION 795 0.0154
145 SPONDYLITIS 56 0.0154
146 SINUS DISORDER 304 0.0153
147 SINUS HEADACHE 91 0.0153
148 PARAESTHESIA 2409 0.0153
149 BLOOD TRIGLYCERIDES INCREASED 268 0.0152
150 INCREASED TENDENCY TO BRUISE 139 0.0151
151 ROTATOR CUFF SYNDROME 194 0.0151
152 RED BLOOD CELL SEDIMENTATION RATE INCREASED 167 0.0151
153 DECREASED INTEREST 89 0.0151
154 DIZZINESS POSTURAL 145 0.0149
155 DIABETIC NEUROPATHY 74 0.0149
156 INFUSION SITE SWELLING 94 0.0149
157 THERAPEUTIC PRODUCT EFFECT DECREASED 662 0.0148
158 TENDERNESS 154 0.0148
159 DIVERTICULUM 105 0.0148
160 FACE INJURY 56 0.0147
161 ROSACEA 68 0.0146
162 SINUS CONGESTION 197 0.0146
163 SNORING 55 0.0145
164 THERAPY NON-RESPONDER 654 0.0145
165 BLOOD URIC ACID INCREASED 84 0.0145
166 SYNOVIAL CYST 67 0.0145
167 VITAMIN D DEFICIENCY 141 0.0144
168 SPINAL OSTEOARTHRITIS 126 0.0143
169 INJURY 1001 0.0142
170 CARPAL TUNNEL SYNDROME 198 0.0141
171 MIDDLE INSOMNIA 264 0.0141
172 CORONARY ARTERY OCCLUSION 193 0.0141
173 PREGNANCY 281 0.0140
174 MUSCLE STRAIN 121 0.0140
175 WEIGHT FLUCTUATION 146 0.0139
176 VITREOUS FLOATERS 137 0.0139
177 GOUT 250 0.0139
178 SQUAMOUS CELL CARCINOMA OF SKIN 84 0.0139
179 JOINT DISLOCATION 147 0.0139
180 EYE INFECTION 157 0.0139
181 ABDOMINAL DISCOMFORT 2326 0.0139
182 DYSPEPSIA 1361 0.0138
183 MICTURITION URGENCY 158 0.0138
184 RHEUMATOID ARTHRITIS 1566 0.0138
185 OSTEOPENIA 208 0.0137
186 FOREIGN BODY SENSATION IN EYES 87 0.0136
187 DRY EYE 681 0.0136
188 LIGAMENT RUPTURE 60 0.0136
189 SKIN ATROPHY 78 0.0135
190 INITIAL INSOMNIA 139 0.0135
191 HYPOAESTHESIA 2002 0.0134
192 NASOPHARYNGITIS 2461 0.0133
193 BLOOD MAGNESIUM DECREASED 115 0.0133
194 ERYTHEMA OF EYELID 72 0.0133
195 MUSCLE SPASMS 2432 0.0132
196 GENERALISED ERYTHEMA 75 0.0132
197 HAIR COLOUR CHANGES 164 0.0132
198 HAIR TEXTURE ABNORMAL 175 0.0131
199 OCULAR DISCOMFORT 146 0.0130
200 MELANOCYTIC NAEVUS 57 0.0130
201 END STAGE RENAL DISEASE 237 0.0130
202 GROIN PAIN 114 0.0130
203 MACULAR DEGENERATION 155 0.0130
204 GASTROENTERITIS VIRAL 234 0.0129
205 NEURALGIA 315 0.0129
206 IRON DEFICIENCY 58 0.0129
207 LIVER DISORDER 571 0.0129
208 LACERATION 121 0.0129
209 ORAL PAIN 288 0.0128
210 JOINT STIFFNESS 337 0.0128
211 DISABILITY 254 0.0128
212 CARDIAC FLUTTER 83 0.0128
213 HOT FLUSH 966 0.0128
214 CHRONIC KIDNEY DISEASE 972 0.0128
215 ABDOMINAL PAIN UPPER 2633 0.0128
216 INFUSION SITE PAIN 164 0.0127
217 NOCTURIA 154 0.0127
218 EAR DISCOMFORT 130 0.0127
219 URTICARIA 2119 0.0126
220 ALOPECIA 2483 0.0126
221 PHOTOPHOBIA 235 0.0125
222 INCREASED UPPER AIRWAY SECRETION 64 0.0125
223 INFUSION SITE ERYTHEMA 105 0.0124
224 BALANCE DISORDER 1070 0.0124
225 ILL-DEFINED DISORDER 746 0.0123
226 BASAL CELL CARCINOMA 191 0.0122
227 LUPUS-LIKE SYNDROME 111 0.0122
228 GASTROINTESTINAL DISORDER 1094 0.0122
229 INSOMNIA 3237 0.0121
230 BRONCHITIS 899 0.0121
231 PERONEAL NERVE PALSY 69 0.0121
232 TENDONITIS 188 0.0121
233 LIGAMENT SPRAIN 120 0.0121
234 PRURITUS GENERALISED 262 0.0121
235 INTERVERTEBRAL DISC PROTRUSION 263 0.0120
236 SENSORY DISTURBANCE 193 0.0120
237 AMNESIA 781 0.0120
238 AGEUSIA 299 0.0120
239 NECK PAIN 668 0.0119
240 NERVE COMPRESSION 110 0.0119
241 MUSCULAR WEAKNESS 1354 0.0119
242 FULL BLOOD COUNT DECREASED 240 0.0119
243 URINE ODOUR ABNORMAL 70 0.0119
244 PROSTATIC SPECIFIC ANTIGEN INCREASED 164 0.0119
245 POOR QUALITY SLEEP 255 0.0118
246 MEMORY IMPAIRMENT 1626 0.0118
247 RASH PRURITIC 641 0.0118
248 TENDON RUPTURE 146 0.0118
249 MUSCULOSKELETAL CHEST PAIN 183 0.0118
250 FREQUENT BOWEL MOVEMENTS 319 0.0118
251 MUSCLE TIGHTNESS 191 0.0118
252 WEIGHT INCREASED 2640 0.0118
253 HEART RATE IRREGULAR 266 0.0118
254 CONCUSSION 91 0.0117
255 LOCAL SWELLING 205 0.0117
256 TEMPERATURE INTOLERANCE 121 0.0117
257 HAEMORRHOIDAL HAEMORRHAGE 57 0.0117
258 MIGRAINE 1113 0.0116
259 FLATULENCE 661 0.0116
260 ASTHENOPIA 64 0.0116
261 UPPER RESPIRATORY TRACT INFECTION 538 0.0116
262 LOWER GASTROINTESTINAL HAEMORRHAGE 86 0.0116
263 POLLAKIURIA 485 0.0116
264 ONYCHOCLASIS 80 0.0116
265 HYPERKERATOSIS 64 0.0116
266 PRURITUS 4449 0.0116
267 HAIR GROWTH ABNORMAL 80 0.0115
268 LACRIMATION INCREASED 349 0.0115
269 PAIN IN EXTREMITY 3398 0.0115
270 SKIN LACERATION 125 0.0115
271 BACK PAIN 2663 0.0115
272 EAR INFECTION 305 0.0114
273 CHEST PAIN 2121 0.0114
274 BENIGN PROSTATIC HYPERPLASIA 59 0.0114
275 ARTHRITIS 897 0.0114
276 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 195 0.0114
277 MUSCLE DISORDER 92 0.0113
278 GAIT DISTURBANCE 2173 0.0113
279 ARTHRALGIA 4717 0.0113
280 TONGUE DISORDER 82 0.0113
281 CONFUSIONAL STATE 1830 0.0113
282 BREAST MASS 76 0.0113
283 CATARACT OPERATION 67 0.0113
284 BLOOD URINE PRESENT 214 0.0113
285 WRIST FRACTURE 135 0.0113
286 FOOD POISONING 60 0.0112
287 TENDON DISORDER 73 0.0112
288 NASAL DRYNESS 70 0.0112
289 JOINT EFFUSION 77 0.0112
290 MUSCULOSKELETAL DISCOMFORT 192 0.0111
291 RED BLOOD CELL COUNT DECREASED 318 0.0111
292 EXERCISE TOLERANCE DECREASED 64 0.0111
293 ASTHENIA 4179 0.0111
294 BURNING SENSATION 779 0.0111
295 GASTROINTESTINAL SOUNDS ABNORMAL 55 0.0111
296 BLADDER DISORDER 110 0.0111
297 EYE DISCHARGE 115 0.0111
298 OSTEOPOROSIS 454 0.0110
299 FEELING JITTERY 210 0.0110
300 DERMATITIS CONTACT 125 0.0109
301 CYST 136 0.0109
302 HEART RATE ABNORMAL 61 0.0109
303 STRESS FRACTURE 59 0.0109
304 OEDEMA PERIPHERAL 1331 0.0109
305 HYPERSOMNIA 312 0.0109
306 BLOOD IRON DECREASED 129 0.0109
307 FATIGUE 8464 0.0109
308 CYSTITIS 345 0.0108
309 RENAL CYST 86 0.0108
310 HIATUS HERNIA 140 0.0108
311 GINGIVAL PAIN 86 0.0108
312 FLUID RETENTION 549 0.0108
313 INTENTIONAL PRODUCT USE ISSUE 945 0.0108
314 PELVIC FRACTURE 84 0.0108
315 SCAB 123 0.0108
316 BRAIN FOG 169 0.0108
317 ACTIVITIES OF DAILY LIVING IMPAIRED 212 0.0107
318 NERVE INJURY 119 0.0107
319 PRODUCT SUBSTITUTION ISSUE 616 0.0107
320 EYE IRRITATION 615 0.0107
321 DRUG INTOLERANCE 1031 0.0107
322 POST-TRAUMATIC STRESS DISORDER 71 0.0106
323 HAIR DISORDER 87 0.0105
324 RESTLESS LEGS SYNDROME 192 0.0105
325 RIB FRACTURE 217 0.0105
326 LABORATORY TEST ABNORMAL 311 0.0105
327 RESPIRATORY TRACT CONGESTION 167 0.0105
328 SCOLIOSIS 65 0.0105
329 BLOOD POTASSIUM INCREASED 170 0.0105
330 TOOTH INFECTION 138 0.0105
331 ARTERIOSCLEROSIS CORONARY ARTERY 69 0.0104
332 ARTHROPOD BITE 77 0.0104
333 BLOOD POTASSIUM DECREASED 312 0.0104
334 FEELING DRUNK 77 0.0104
335 CONSTIPATION 2251 0.0103
336 MYALGIA 1753 0.0103
337 MADAROSIS 119 0.0102
338 DEPRESSION 2332 0.0102
339 LIMB DISCOMFORT 317 0.0102
340 THERAPEUTIC RESPONSE UNEXPECTED 459 0.0102
341 VENTRICULAR EXTRASYSTOLES 106 0.0102
342 IMPAIRED DRIVING ABILITY 116 0.0102
343 SKIN HAEMORRHAGE 151 0.0102
344 ULCER 162 0.0102
345 NEPHROLITHIASIS 466 0.0101
346 PRODUCT FORMULATION ISSUE 67 0.0101
347 HYPERTENSION 2146 0.0101
348 PNEUMONIA ASPIRATION 253 0.0101
349 LYMPHOEDEMA 70 0.0101
350 NORMAL NEWBORN 55 0.0101
351 DELIRIUM 351 0.0101
352 RHINORRHOEA 651 0.0101
353 STENT PLACEMENT 81 0.0100
354 JAW DISORDER 55 0.0100
355 CATARACT 597 0.0100
356 FOOT FRACTURE 190 0.0100
357 ANKLE FRACTURE 155 0.0100
358 BONE DISORDER 182 0.0100
359 SNEEZING 224 0.0100
360 SQUAMOUS CELL CARCINOMA 94 0.0100
361 LIMB INJURY 271 0.0100
362 FACIAL PAIN 89 0.0100
363 LARGE INTESTINE POLYP 69 0.0100
364 OROPHARYNGEAL PAIN 922 0.0099
365 TOOTH DISORDER 221 0.0099
366 TINNITUS 456 0.0099
367 HEAD INJURY 314 0.0099
368 NEUROPATHY PERIPHERAL 943 0.0099
369 SOMNAMBULISM 65 0.0099
370 DECREASED APPETITE 2299 0.0099
371 ABNORMAL FAECES 81 0.0099
372 HEAD DISCOMFORT 175 0.0099
373 NASAL CONGESTION 580 0.0099
374 HYPERAESTHESIA 81 0.0099
375 DRY THROAT 100 0.0098
376 URINARY INCONTINENCE 291 0.0098
377 BLOOD SODIUM DECREASED 185 0.0098
378 PHOTOPSIA 62 0.0098
379 DIZZINESS 4883 0.0098
380 DYSPHONIA 572 0.0098
381 POLYP 64 0.0098
382 EYE HAEMORRHAGE 130 0.0097
383 HEPATIC CIRRHOSIS 183 0.0097
384 FAECES DISCOLOURED 211 0.0097
385 PERIORBITAL SWELLING 55 0.0097
386 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 165 0.0097
387 DYSGEUSIA 719 0.0097
388 PAIN IN JAW 274 0.0097
389 ENERGY INCREASED 57 0.0096
390 LIVER FUNCTION TEST INCREASED 207 0.0096
391 HAEMORRHOIDS 188 0.0096
392 FORMICATION 67 0.0096
393 FEELING COLD 268 0.0096
394 TOOTHACHE 174 0.0096
395 HAND FRACTURE 68 0.0096
396 JOINT INJURY 205 0.0096
397 IMPAIRED WORK ABILITY 205 0.0096
398 THERAPY CESSATION 492 0.0096
399 DIARRHOEA 6166 0.0095
400 LOCALISED INFECTION 231 0.0095
401 MYASTHENIA GRAVIS 77 0.0095
402 BOWEL MOVEMENT IRREGULARITY 73 0.0095
403 BLOOD PRESSURE INCREASED 1457 0.0095
404 ATRIAL FLUTTER 76 0.0095
405 FLANK PAIN 89 0.0095
406 ASTHMA 1073 0.0095
407 INFECTION 1371 0.0095
408 MUSCLE ATROPHY 120 0.0095
409 PRODUCTIVE COUGH 452 0.0095
410 SKIN FISSURES 185 0.0095
411 BONE PAIN 554 0.0094
412 WHITE BLOOD CELL COUNT INCREASED 362 0.0094
413 RECTAL HAEMORRHAGE 405 0.0094
414 DIVERTICULITIS 261 0.0094
415 PAROSMIA 71 0.0094
416 THIRST 168 0.0094
417 DENTAL CARIES 104 0.0094
418 WEIGHT DECREASED 2618 0.0094
419 HEADACHE 5875 0.0094
420 RASH PAPULAR 210 0.0094
421 GASTROINTESTINAL PAIN 103 0.0094
422 OCULAR HYPERAEMIA 443 0.0093
423 TOOTH ABSCESS 95 0.0093
424 CHROMATURIA 210 0.0093
425 EYE SWELLING 346 0.0093
426 GENERAL PHYSICAL HEALTH DETERIORATION 1076 0.0093
427 VISION BLURRED 1275 0.0093
428 THINKING ABNORMAL 173 0.0093
429 PLATELET COUNT INCREASED 121 0.0093
430 THYROID DISORDER 143 0.0093
431 NODULE 121 0.0093
432 PULMONARY THROMBOSIS 101 0.0093
433 DYSGRAPHIA 61 0.0092
434 ANOSMIA 134 0.0092
435 RENAL PAIN 98 0.0092
436 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 444 0.0092
437 BLOOD PRESSURE FLUCTUATION 221 0.0092
438 EXTRASYSTOLES 64 0.0092
439 ATRIAL FIBRILLATION 891 0.0091
440 ERUCTATION 177 0.0091
441 HEART RATE DECREASED 321 0.0091
442 DYSPNOEA EXERTIONAL 344 0.0091
443 RASH MACULAR 319 0.0091
444 EPISTAXIS 682 0.0091
445 DECREASED ACTIVITY 98 0.0091
446 URINARY TRACT INFECTION 1549 0.0091
447 RASH 3943 0.0090
448 DYSSTASIA 264 0.0090
449 HYPERSENSITIVITY 1671 0.0090
450 PAIN 5511 0.0090
451 FALL 2985 0.0090
452 CHOLECYSTITIS CHRONIC 60 0.0090
453 PERIPHERAL COLDNESS 123 0.0089
454 NASAL DISCOMFORT 71 0.0089
455 BLOOD PRESSURE ABNORMAL 178 0.0089
456 SMALL INTESTINAL OBSTRUCTION 110 0.0089
457 ORAL DISCOMFORT 124 0.0089
458 SLUGGISHNESS 91 0.0089
459 PALPITATIONS 1044 0.0089
460 FEELING ABNORMAL 2120 0.0088
461 FUNGAL INFECTION 294 0.0088
462 COUGH 2473 0.0088
463 PARAESTHESIA ORAL 127 0.0088
464 SKIN DISCOLOURATION 404 0.0088
465 GINGIVAL BLEEDING 120 0.0088
466 HYPERTRANSAMINASAEMIA 61 0.0088
467 ABNORMAL DREAMS 242 0.0088
468 POSTOPERATIVE WOUND INFECTION 59 0.0087
469 PULMONARY MASS 130 0.0087
470 PROCTALGIA 56 0.0087
471 GLOMERULAR FILTRATION RATE DECREASED 107 0.0087
472 BLOOD COUNT ABNORMAL 132 0.0087
473 INCONTINENCE 92 0.0087
474 ATELECTASIS 84 0.0087
475 ABDOMINAL DISTENSION 907 0.0087
476 GALLBLADDER DISORDER 155 0.0087
477 UPPER LIMB FRACTURE 173 0.0087
478 TROPONIN INCREASED 66 0.0087
479 CELLULITIS 437 0.0087
480 CHILLS 1016 0.0087
481 IRON DEFICIENCY ANAEMIA 80 0.0087
482 FAECES SOFT 63 0.0087
483 PRESYNCOPE 210 0.0086
484 SPLENOMEGALY 101 0.0086
485 HUNGER 120 0.0086
486 ANXIETY 2445 0.0086
487 INSURANCE ISSUE 131 0.0086
488 CARDIAC MURMUR 74 0.0085
489 INJECTION SITE HAEMATOMA 124 0.0085
490 TOOTH FRACTURE 94 0.0085
491 ARTERIAL OCCLUSIVE DISEASE 67 0.0085
492 SKIN DISORDER 284 0.0085
493 HERPES ZOSTER 489 0.0085
494 HEART RATE INCREASED 843 0.0085
495 ABNORMAL LOSS OF WEIGHT 58 0.0085
496 QUALITY OF LIFE DECREASED 114 0.0085
497 POST PROCEDURAL INFECTION 69 0.0085
498 THROAT IRRITATION 380 0.0085
499 VERTIGO 516 0.0085
500 THERMAL BURN 60 0.0084
501 THERAPY CHANGE 83 0.0084
502 SCRATCH 89 0.0084
503 HERNIA 163 0.0084
504 HEPATIC STEATOSIS 157 0.0084
505 DYSURIA 310 0.0084
506 AORTIC ANEURYSM 64 0.0084
507 CHEST DISCOMFORT 860 0.0084
508 SKIN MASS 56 0.0084
509 COELIAC DISEASE 82 0.0084
510 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 435 0.0083
511 SPUTUM DISCOLOURED 79 0.0083
512 VIRAL INFECTION 277 0.0083
513 UPPER GASTROINTESTINAL HAEMORRHAGE 140 0.0083
514 GLAUCOMA 160 0.0083
515 MITRAL VALVE INCOMPETENCE 94 0.0083
516 C-REACTIVE PROTEIN INCREASED 302 0.0083
517 FOOD ALLERGY 64 0.0083
518 DIPLOPIA 215 0.0083
519 INCREASED APPETITE 158 0.0083
520 APPENDICITIS 77 0.0082
521 WHITE BLOOD CELL COUNT DECREASED 893 0.0082
522 ARTERIOSCLEROSIS 77 0.0082
523 TRICUSPID VALVE INCOMPETENCE 65 0.0082
524 BREAST PAIN 87 0.0081
525 MUSCLE TWITCHING 188 0.0081
526 SUPRAVENTRICULAR TACHYCARDIA 78 0.0081
527 RESPIRATORY TRACT INFECTION 212 0.0081
528 PHARYNGITIS STREPTOCOCCAL 88 0.0081
529 SPINAL DISORDER 77 0.0081
530 ECONOMIC PROBLEM 123 0.0081
531 PSORIASIS 1060 0.0081
532 INCORRECT DRUG ADMINISTRATION DURATION 228 0.0081
533 INFLUENZA LIKE ILLNESS 667 0.0081
534 MATERNAL EXPOSURE DURING PREGNANCY 722 0.0081
535 ABASIA 200 0.0081
536 EYE DISORDER 266 0.0081
537 HAEMATOCRIT DECREASED 160 0.0081
538 RETINAL DETACHMENT 74 0.0080
539 CONDITION AGGRAVATED 2445 0.0080
540 SKIN CANCER 173 0.0080
541 KNEE OPERATION 79 0.0080
542 IMPAIRED QUALITY OF LIFE 115 0.0080
543 PANIC ATTACK 291 0.0080
544 STAPHYLOCOCCAL INFECTION 263 0.0080
545 INJECTION SITE PRURITUS 534 0.0080
546 ACUTE RESPIRATORY FAILURE 153 0.0079
547 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 565 0.0079
548 SOMNOLENCE 1599 0.0079
549 CANDIDA INFECTION 134 0.0079
550 NERVOUSNESS 414 0.0079
551 APHONIA 110 0.0079
552 PSYCHOLOGICAL TRAUMA 68 0.0079
553 CHOLELITHIASIS 258 0.0079
554 DYSPNOEA 4445 0.0078
555 INJECTION SITE BRUISING 626 0.0078
556 SPINAL FRACTURE 157 0.0078
557 RETCHING 167 0.0078
558 NEPHROPATHY 73 0.0078
559 INJECTION SITE NODULE 86 0.0078
560 SUNBURN 58 0.0078
561 NAUSEA 6153 0.0078
562 TRANSIENT ISCHAEMIC ATTACK 262 0.0078
563 MALIGNANT MELANOMA 104 0.0078
564 SKIN INFECTION 87 0.0077
565 LYMPHOCYTE COUNT DECREASED 137 0.0077
566 ORAL HERPES 151 0.0077
567 TREATMENT FAILURE 640 0.0077
568 SPINAL OPERATION 95 0.0077
569 FURUNCLE 61 0.0077
570 IMMUNE SYSTEM DISORDER 101 0.0077
571 FULL BLOOD COUNT ABNORMAL 81 0.0077
572 LYMPHADENOPATHY 271 0.0076
573 CLOSTRIDIUM DIFFICILE INFECTION 167 0.0076
574 GLYCOSYLATED HAEMOGLOBIN INCREASED 193 0.0076
575 ORAL DISORDER 56 0.0076
576 AFFECTIVE DISORDER 60 0.0076
577 ANGER 258 0.0076
578 SKIN LESION 209 0.0076
579 BODY TEMPERATURE DECREASED 75 0.0076
580 WRONG TECHNIQUE IN DRUG USAGE PROCESS 276 0.0076
581 SPINAL PAIN 89 0.0076
582 ERYTHEMA 1561 0.0076
583 SECRETION DISCHARGE 95 0.0076
584 VISUAL IMPAIRMENT 938 0.0076
585 PHOTOSENSITIVITY REACTION 125 0.0076
586 PNEUMONIA 2449 0.0076
587 URINE OUTPUT DECREASED 66 0.0075
588 PRODUCT DISTRIBUTION ISSUE 70 0.0075
589 COLD SWEAT 133 0.0075
590 DRUG EFFECT INCOMPLETE 274 0.0075
591 OROPHARYNGEAL DISCOMFORT 68 0.0075
592 ORAL CANDIDIASIS 99 0.0075
593 SPINAL COMPRESSION FRACTURE 62 0.0075
594 HYPERHIDROSIS 966 0.0075
595 SENSATION OF FOREIGN BODY 63 0.0075
596 MUSCULOSKELETAL DISORDER 142 0.0075
597 COORDINATION ABNORMAL 104 0.0074
598 ANAL INCONTINENCE 67 0.0074
599 DRUG DOSE OMISSION 1225 0.0074
600 BLOOD TEST ABNORMAL 104 0.0074
601 HIP FRACTURE 238 0.0074
602 GASTROINTESTINAL HAEMORRHAGE 618 0.0074
603 ADVERSE DRUG REACTION 661 0.0074
604 PULMONARY CONGESTION 97 0.0074
605 PULMONARY HYPERTENSION 153 0.0073
606 KIDNEY INFECTION 144 0.0073
607 ABDOMINAL PAIN 1705 0.0073
608 FEAR 197 0.0073
609 IMMUNODEFICIENCY 109 0.0073
610 THROMBOSIS 588 0.0073
611 SCAR 125 0.0073
612 DEHYDRATION 973 0.0073
613 EYE PRURITUS 245 0.0073
614 PETECHIAE 76 0.0073
615 DEPRESSED MOOD 385 0.0073
616 COGNITIVE DISORDER 340 0.0073
617 EATING DISORDER 155 0.0073
618 CHOLECYSTECTOMY 83 0.0073
619 ELECTROCARDIOGRAM ABNORMAL 57 0.0073
620 GASTROINTESTINAL INFECTION 65 0.0072
621 VOMITING 3405 0.0072
622 INFLUENZA 807 0.0072
623 HYPOKINESIA 105 0.0072
624 MASS 101 0.0072
625 TREMOR 1198 0.0072
626 THROAT TIGHTNESS 195 0.0072
627 INJECTION SITE DISCOLOURATION 90 0.0072
628 HYPOPHAGIA 184 0.0072
629 SKIN ULCER 186 0.0072
630 DISTURBANCE IN ATTENTION 388 0.0072
631 RHINITIS 58 0.0072
632 BLOOD THYROID STIMULATING HORMONE INCREASED 66 0.0072
633 BLOOD UREA INCREASED 120 0.0072
634 CORONARY ARTERY DISEASE 217 0.0072
635 LETHARGY 412 0.0072
636 SKIN BURNING SENSATION 512 0.0071
637 MENTAL IMPAIRMENT 173 0.0071
638 SKIN EXFOLIATION 601 0.0071
639 PRODUCT USE ISSUE 1329 0.0071
640 THERAPEUTIC RESPONSE DECREASED 428 0.0071
641 INTENTIONAL PRODUCT MISUSE 618 0.0071
642 PANCREATITIS 373 0.0070
643 HYSTERECTOMY 61 0.0070
644 HYPOAESTHESIA ORAL 106 0.0070
645 CHOKING 137 0.0070
646 GASTROINTESTINAL INFLAMMATION 55 0.0070
647 BLOOD PRESSURE DECREASED 464 0.0070
648 HAEMOGLOBIN DECREASED 717 0.0070
649 HAEMATOCHEZIA 384 0.0070
650 RASH GENERALISED 180 0.0069
651 PYREXIA 2404 0.0069
652 RASH ERYTHEMATOUS 332 0.0069
653 DRUG ADMINISTERED AT INAPPROPRIATE SITE 73 0.0069
654 HYPOTHYROIDISM 221 0.0069
655 APHASIA 208 0.0069
656 MOVEMENT DISORDER 221 0.0069
657 GASTRIC DISORDER 236 0.0069
658 MOTOR DYSFUNCTION 70 0.0069
659 DRY SKIN 916 0.0069
660 INJECTION SITE URTICARIA 167 0.0068
661 BLOOD PRESSURE SYSTOLIC INCREASED 132 0.0068
662 DRUG EFFECT DECREASED 364 0.0068
663 PRODUCT QUALITY ISSUE 916 0.0067
664 INJECTION SITE ERYTHEMA 836 0.0067
665 IRRITABILITY 405 0.0067
666 BLOOD GLUCOSE INCREASED 1264 0.0067
667 RENAL INJURY 199 0.0067
668 ERECTILE DYSFUNCTION 172 0.0067
669 HOSPICE CARE 66 0.0067
670 PERSONALITY CHANGE 62 0.0067
671 DEAFNESS 174 0.0066
672 CARDIAC FAILURE CONGESTIVE 534 0.0066
673 HALLUCINATION 500 0.0066
674 INJECTION SITE INDURATION 86 0.0066
675 INTENTIONAL DOSE OMISSION 189 0.0066
676 EYE INFLAMMATION 63 0.0066
677 SPEECH DISORDER 345 0.0066
678 EPILEPSY 201 0.0066
679 SWOLLEN TONGUE 205 0.0066
680 POST PROCEDURAL COMPLICATION 126 0.0066
681 MALAISE 2875 0.0065
682 CENTRAL NERVOUS SYSTEM LESION 90 0.0065
683 EYELID OEDEMA 76 0.0065
684 NIGHTMARE 226 0.0065
685 IMPAIRED GASTRIC EMPTYING 89 0.0065
686 APATHY 95 0.0065
687 ANHEDONIA 171 0.0065
688 MOOD ALTERED 177 0.0065
689 ADVERSE EVENT 598 0.0065
690 BEDRIDDEN 85 0.0065
691 MOOD SWINGS 206 0.0065
692 GASTRITIS 170 0.0065
693 BLINDNESS UNILATERAL 91 0.0064
694 MULTIPLE SCLEROSIS 308 0.0064
695 PARANOIA 111 0.0064
696 UNEVALUABLE EVENT 485 0.0064
697 INJECTION SITE REACTION 441 0.0064
698 APPLICATION SITE PAIN 141 0.0064
699 PLATELET COUNT DECREASED 682 0.0064
700 COVID-19 1122 0.0064
701 INJECTION SITE RASH 196 0.0064
702 PRODUCT DOSE OMISSION 417 0.0064
703 INJECTION SITE WARMTH 131 0.0064
704 DIABETES MELLITUS 485 0.0064
705 CONJUNCTIVITIS 118 0.0064
706 BIPOLAR DISORDER 69 0.0063
707 SKIN SWELLING 55 0.0063
708 MULTIPLE SCLEROSIS RELAPSE 434 0.0063
709 SWELLING FACE 412 0.0063
710 RENAL DISORDER 294 0.0063
711 ASPIRATION 69 0.0063
712 RENAL FAILURE 835 0.0063
713 CARDIAC OPERATION 54 0.0063
714 CRYING 228 0.0063
715 POST PROCEDURAL HAEMORRHAGE 73 0.0063
716 CARDIOMEGALY 77 0.0063
717 BLOOD CALCIUM DECREASED 70 0.0062
718 CLOSTRIDIUM DIFFICILE COLITIS 66 0.0062
719 DEEP VEIN THROMBOSIS 404 0.0062
720 UNDERDOSE 453 0.0062
721 EYELID PTOSIS 63 0.0062
722 HEMIPARESIS 105 0.0062
723 LIP SWELLING 206 0.0062
724 OSTEOMYELITIS 112 0.0062
725 OXYGEN SATURATION DECREASED 347 0.0062
726 DYSPHAGIA 586 0.0062
727 VISUAL ACUITY REDUCED 205 0.0062
728 GASTRIC ULCER 117 0.0061
729 DRUG EFFECT LESS THAN EXPECTED 91 0.0061
730 HAEMATOMA 159 0.0061
731 OESOPHAGITIS 67 0.0061
732 HYPOACUSIS 264 0.0061
733 BACTERIAL INFECTION 114 0.0061
734 INTERNATIONAL NORMALISED RATIO INCREASED 174 0.0061
735 PAIN OF SKIN 164 0.0061
736 SURGERY 357 0.0061
737 INJECTION SITE HAEMORRHAGE 486 0.0061
738 EXPOSURE DURING PREGNANCY 378 0.0061
739 DISORIENTATION 241 0.0061
740 INJECTION SITE EXTRAVASATION 75 0.0061
741 DYSKINESIA 246 0.0060
742 ACCIDENT 72 0.0060
743 OVARIAN CYST 60 0.0060
744 COAGULOPATHY 100 0.0060
745 DIARRHOEA HAEMORRHAGIC 56 0.0060
746 ANAEMIA 1137 0.0060
747 BLOOD CREATININE INCREASED 389 0.0060
748 BLOOD GLUCOSE DECREASED 286 0.0059
749 EMPHYSEMA 60 0.0059
750 SUBDURAL HAEMATOMA 85 0.0059
751 ANGINA PECTORIS 170 0.0059
752 EXPIRED PRODUCT ADMINISTERED 197 0.0059
753 AFFECT LABILITY 57 0.0059
754 FEEDING DISORDER 120 0.0059
755 PHARYNGEAL OEDEMA 91 0.0059
756 PROCEDURAL PAIN 164 0.0059
757 SARS-COV-2 TEST POSITIVE 78 0.0059
758 EMOTIONAL DISORDER 182 0.0059
759 DYSARTHRIA 222 0.0059
760 INJECTION SITE PAIN 1800 0.0059
761 VENTRICULAR FIBRILLATION 65 0.0058
762 COLITIS ULCERATIVE 261 0.0058
763 PHARYNGITIS 72 0.0058
764 PRODUCT DOSE OMISSION IN ERROR 164 0.0058
765 URINARY RETENTION 193 0.0058
766 INJECTION SITE SWELLING 442 0.0058
767 APPLICATION SITE RASH 79 0.0057
768 INJECTION SITE MASS 212 0.0057
769 HAEMATURIA 196 0.0057
770 RESPIRATORY DEPRESSION 70 0.0057
771 MEDICATION ERROR 317 0.0057
772 COVID-19 PNEUMONIA 67 0.0057
773 PSYCHOMOTOR HYPERACTIVITY 94 0.0057
774 BLOOD GLUCOSE FLUCTUATION 62 0.0057
775 WITHDRAWAL SYNDROME 237 0.0056
776 INTRAOCULAR PRESSURE INCREASED 72 0.0056
777 TOOTH EXTRACTION 70 0.0056
778 MENTAL STATUS CHANGES 156 0.0056
779 INJECTION SITE DISCOMFORT 59 0.0056
780 APPLICATION SITE ERYTHEMA 147 0.0056
781 HEREDITARY ANGIOEDEMA 60 0.0056
782 HYPERCALCAEMIA 69 0.0056
783 RESTLESSNESS 204 0.0056
784 ORTHOSTATIC HYPOTENSION 97 0.0056
785 THERAPY INTERRUPTED 398 0.0056
786 DELUSION 86 0.0055
787 FEMUR FRACTURE 171 0.0055
788 PRODUCT USE IN UNAPPROVED INDICATION 1368 0.0055
789 INTENTIONAL DRUG MISUSE 115 0.0055
790 ATAXIA 65 0.0055
791 PULMONARY EMBOLISM 516 0.0054
792 ILLNESS 559 0.0054
793 BLOOD GLUCOSE ABNORMAL 100 0.0054
794 PRODUCT DOSE OMISSION ISSUE 1582 0.0054
795 PARALYSIS 77 0.0054
796 SYNCOPE 537 0.0054
797 SUICIDAL IDEATION 490 0.0053
798 ACUTE KIDNEY INJURY 818 0.0053
799 DERMATITIS 112 0.0053
800 HAEMOPTYSIS 149 0.0053
801 LOSS OF CONSCIOUSNESS 684 0.0053
802 PLEURAL EFFUSION 323 0.0053
803 APPLICATION SITE IRRITATION 66 0.0053
804 CARDIAC DISORDER 496 0.0053
805 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 123 0.0053
806 ECZEMA 276 0.0053
807 HYPOTENSION 1057 0.0053
808 LIVER FUNCTION TEST ABNORMAL 153 0.0053
809 DISEASE RECURRENCE 250 0.0053
810 RENAL FAILURE ACUTE 222 0.0052
811 LUNG INFECTION 81 0.0052
812 HYPOXIA 183 0.0052
813 INJECTION SITE IRRITATION 66 0.0052
814 MALNUTRITION 58 0.0052
815 MOUTH ULCERATION 109 0.0052
816 HALLUCINATION, VISUAL 109 0.0052
817 APPLICATION SITE PRURITUS 117 0.0052
818 PLASMA CELL MYELOMA 201 0.0051
819 PELVIC PAIN 93 0.0051
820 DEMENTIA 143 0.0051
821 DRUG ADMINISTRATION ERROR 156 0.0051
822 ELECTROLYTE IMBALANCE 59 0.0051
823 ADVERSE REACTION 67 0.0050
824 PRODUCT USE COMPLAINT 79 0.0050
825 ABSCESS 80 0.0050
826 NO THERAPEUTIC RESPONSE 61 0.0050
827 COMA 238 0.0050
828 SEXUAL DYSFUNCTION 58 0.0049
829 ADRENAL INSUFFICIENCY 60 0.0049
830 LEUKOCYTOSIS 89 0.0049
831 SEPSIS 546 0.0049
832 DRUG-INDUCED LIVER INJURY 153 0.0049
833 HAEMORRHAGE 509 0.0049
834 MANIA 80 0.0049
835 SKIN REACTION 68 0.0048
836 NEOPLASM 55 0.0048
837 DERMATITIS ATOPIC 252 0.0048
838 DRUG INEFFECTIVE 6296 0.0048
839 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 339 0.0048
840 PERICARDIAL EFFUSION 110 0.0048
841 AGITATION 349 0.0047
842 CARDIOMYOPATHY 70 0.0047
843 RENAL IMPAIRMENT 396 0.0047
844 COLON CANCER 70 0.0047
845 ABNORMAL BEHAVIOUR 186 0.0047
846 INCORRECT PRODUCT ADMINISTRATION DURATION 101 0.0047
847 PRODUCT ADMINISTRATION ERROR 94 0.0046
848 TREATMENT NONCOMPLIANCE 254 0.0046
849 INCORRECT DOSE ADMINISTERED 1057 0.0046
850 MULTIPLE FRACTURES 76 0.0046
851 PRODUCT PRESCRIBING ERROR 110 0.0046
852 CHOLECYSTITIS 55 0.0046
853 ASPARTATE AMINOTRANSFERASE INCREASED 245 0.0046
854 DERMATITIS ALLERGIC 58 0.0046
855 LYMPHOMA 71 0.0046
856 ALANINE AMINOTRANSFERASE INCREASED 282 0.0046
857 PULMONARY OEDEMA 205 0.0046
858 HYPERTHYROIDISM 66 0.0046
859 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 818 0.0045
860 PRODUCT TASTE ABNORMAL 61 0.0045
861 PANCREATITIS ACUTE 101 0.0045
862 DEVICE RELATED INFECTION 69 0.0045
863 TUBULOINTERSTITIAL NEPHRITIS 84 0.0045
864 ARRHYTHMIA 212 0.0045
865 UNRESPONSIVE TO STIMULI 115 0.0045
866 OFF LABEL USE 3900 0.0044
867 DYSMENORRHOEA 59 0.0044
868 ACNE 335 0.0044
869 CEREBRAL HAEMORRHAGE 158 0.0044
870 MELAENA 97 0.0044
871 CEREBROVASCULAR ACCIDENT 745 0.0044
872 COLITIS 166 0.0044
873 MENTAL DISORDER 190 0.0044
874 BLOOD ALKALINE PHOSPHATASE INCREASED 108 0.0043
875 ACUTE MYOCARDIAL INFARCTION 128 0.0043
876 ABDOMINAL PAIN LOWER 109 0.0043
877 THERAPEUTIC RESPONSE SHORTENED 142 0.0043
878 INTESTINAL OBSTRUCTION 159 0.0042
879 FLUID OVERLOAD 61 0.0042
880 DRUG DISPENSING ERROR 64 0.0042
881 INCORRECT PRODUCT STORAGE 55 0.0042
882 SKIN IRRITATION 191 0.0042
883 DRUG PRESCRIBING ERROR 80 0.0042
884 MYOCARDIAL INFARCTION 725 0.0042
885 SEIZURE 477 0.0041
886 FRACTURE 78 0.0041
887 PALLOR 111 0.0041
888 PULMONARY ARTERIAL HYPERTENSION 59 0.0041
889 NEOPLASM PROGRESSION 140 0.0040
890 VAGINAL HAEMORRHAGE 173 0.0040
891 CARDIOGENIC SHOCK 57 0.0040
892 HAEMORRHAGE INTRACRANIAL 59 0.0039
893 DEVICE MALFUNCTION 277 0.0039
894 PRODUCT PHYSICAL ISSUE 79 0.0039
895 GASTROENTERITIS 57 0.0039
896 PROTEINURIA 74 0.0039
897 NEUTROPHIL COUNT DECREASED 157 0.0038
898 BLINDNESS 156 0.0038
899 HYPONATRAEMIA 211 0.0037
900 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 205 0.0037
901 PRODUCT AVAILABILITY ISSUE 85 0.0037
902 DIABETES MELLITUS INADEQUATE CONTROL 66 0.0037
903 BONE LOSS 56 0.0037
904 AGGRESSION 186 0.0037
905 ASCITES 108 0.0037
906 EJECTION FRACTION DECREASED 57 0.0037
907 BONE DENSITY DECREASED 114 0.0036
908 EXTRA DOSE ADMINISTERED 147 0.0036
909 DRUG INTERACTION 572 0.0036
910 VENTRICULAR TACHYCARDIA 59 0.0036
911 DEVICE ISSUE 317 0.0035
912 HOSPITALISATION 543 0.0035
913 NERVOUS SYSTEM DISORDER 110 0.0035
914 METASTASES TO BONE 57 0.0035
915 METASTASES TO LIVER 61 0.0035
916 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 702 0.0035
917 DISEASE PROGRESSION 406 0.0034
918 TACHYCARDIA 302 0.0034
919 BRADYCARDIA 180 0.0034
920 DEVICE USE ISSUE 59 0.0034
921 SEDATION 88 0.0034
922 HAEMATEMESIS 85 0.0033
923 TOOTH LOSS 68 0.0033
924 PNEUMONITIS 89 0.0033
925 BLOOD BILIRUBIN INCREASED 88 0.0033
926 MENORRHAGIA 63 0.0032
927 NEEDLE ISSUE 93 0.0032
928 NEOPLASM MALIGNANT 213 0.0032
929 ACCIDENTAL OVERDOSE 116 0.0032
930 CONVULSION 175 0.0031
931 EMOTIONAL DISTRESS 369 0.0030
932 RESPIRATORY FAILURE 220 0.0030
933 PSYCHOTIC DISORDER 88 0.0030
934 HYPOKALAEMIA 136 0.0029
935 PANCYTOPENIA 164 0.0029
936 LEUKOPENIA 146 0.0029
937 THROMBOCYTOPENIA 325 0.0029
938 ENCEPHALOPATHY 67 0.0027
939 PRODUCT PREPARATION ERROR 56 0.0027
940 HYPERGLYCAEMIA 97 0.0027
941 TARDIVE DYSKINESIA 75 0.0027
942 HYPOGLYCAEMIA 126 0.0026
943 HEPATOTOXICITY 57 0.0026
944 OSTEONECROSIS OF JAW 63 0.0025
945 CARDIAC FAILURE 204 0.0025
946 PRODUCT PRESCRIBING ISSUE 55 0.0025
947 RESPIRATORY DISTRESS 69 0.0025
948 HYPERKALAEMIA 87 0.0025
949 CARDIAC ARREST 202 0.0024
950 RHABDOMYOLYSIS 101 0.0024
951 LUNG NEOPLASM MALIGNANT 99 0.0024
952 SEPTIC SHOCK 103 0.0024
953 BLOOD CREATINE PHOSPHOKINASE INCREASED 68 0.0024
954 DIABETIC KETOACIDOSIS 56 0.0023
955 MALIGNANT NEOPLASM PROGRESSION 236 0.0023
956 FEBRILE NEUTROPENIA 152 0.0023
957 PRODUCT ADHESION ISSUE 81 0.0023
958 DRUG WITHDRAWAL SYNDROME 198 0.0023
959 INCORRECT ROUTE OF DRUG ADMINISTRATION 80 0.0022
960 DEVICE DISLOCATION 97 0.0022
961 DEATH 1904 0.0022
962 MULTIPLE ORGAN DYSFUNCTION SYNDROME 62 0.0022
963 INCORRECT DOSE ADMINISTERED BY DEVICE 57 0.0022
964 ANAPHYLACTIC REACTION 120 0.0022
965 NEUTROPENIA 294 0.0022
966 HEPATITIS 55 0.0021
967 DEPRESSED LEVEL OF CONSCIOUSNESS 85 0.0021
968 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 72 0.0021
969 ANGIOEDEMA 93 0.0021
970 DEVICE LEAKAGE 88 0.0020
971 ABORTION SPONTANEOUS 81 0.0020
972 BREAST CANCER 188 0.0020
973 NO ADVERSE EVENT 349 0.0019
974 ACCIDENTAL EXPOSURE TO PRODUCT 192 0.0019
975 HEPATIC FAILURE 55 0.0018
976 DEVICE BREAKAGE 73 0.0018
977 PROSTATE CANCER 138 0.0017
978 CARDIO-RESPIRATORY ARREST 68 0.0016
979 PRODUCT STORAGE ERROR 140 0.0016
980 SUICIDE ATTEMPT 94 0.0015
981 OVERDOSE 328 0.0015
982 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 70 0.0015
983 INTERSTITIAL LUNG DISEASE 70 0.0014
984 DEVICE EXPULSION 82 0.0013
985 RENAL CANCER 57 0.0012
986 BLADDER CANCER 66 0.0011
987 DRUG ABUSE 79 0.0009
988 DRUG DEPENDENCE 152 0.0009
989 DEVICE DIFFICULT TO USE 59 0.0009
990 TOXICITY TO VARIOUS AGENTS 148 0.0009
991 COMPLETED SUICIDE 54 0.0006